Tag: Oncology
-
Streamlining Care with Patient Navigation: Improving Timely Anti-HER2 Therapy in Early Breast Cancer in LMICs
Background and Rationale In early breast cancer, HER2-positivity demands timely anti-HER2 therapy to optimize outcomes. In low- and middle-income countries (LMICs), health-system constraints—ranging from fragmented care pathways to access barriers—often delay treatment initiation. This retrospective cohort study investigates whether a structured Patient Navigation Program can shorten the time from diagnosis to the start of anti-HER2…
-
SerpinB3: A Cancer Biomarker That Also Shapes Wound Healing
What is SerpinB3 and why it matters SerpinB3 is a protein that can rise in the bloodstream when the body’s tissues are under stress or damage. While most people associate elevated biomarkers with cancer, SerpinB3 plays a broader role in the body’s protective responses. Researchers are increasingly recognizing that SerpinB3 not only signals potential malignancies…
-
Nanovaccine Promises New Hope Against HPV-Related Cancers
Groundbreaking Nanovaccine Targets HPV-Driven Cancers A new nanovaccine approach developed by researchers at UT Southwestern Medical Center has demonstrated remarkable efficacy against cancers caused by human papillomavirus (HPV) in a late-stage animal model. The study, described by the team as a significant step toward treating HPV-related malignancies, reports tumor eradication in animals with advanced, metastatic…
-
Nanovaccine Offers Hope for HPV-Related Cancer Treatment
Breakthrough Nanovaccine Targets HPV-Related Cancers A novel nanovaccine designed to combat cancers driven by the human papillomavirus (HPV) has demonstrated remarkable effectiveness in an animal model of late-stage metastatic disease. Developed by researchers at UT Southwestern Medical Center, the study highlights a promising approach that could shift the treatment landscape for HPV-associated malignancies, which include…
-
Inflammation Drives Early Lung Cancer: MD Anderson Maps
New Insights into the Onset of Lung Cancer Researchers at The University of Texas MD Anderson Cancer Center have unveiled a landmark approach to understanding how lung cancer begins. By creating high-resolution cellular and molecular maps of lung tissue before and during cancer development, the team shows that chronic inflammation may be a primary driver…
-
Inflammation identified as a key driver in the earliest stages of lung cancer
New insights point to inflammation as a trigger in early lung cancer Researchers at The University of Texas MD Anderson Cancer Center have unveiled high-resolution cellular and molecular maps that illuminate how inflammation may initiate lung cancer in its earliest stages. The study, which charts the lung’s microenvironment before and during tumor development, suggests that…
-
SUPREMO Trial: Rethinking Postmastectomy Radiotherapy
Overview: A Shift in Postmastectomy Strategy The international phase 3 SUPREMO trial is reshaping how clinicians treat intermediate-risk early breast cancer (eBC) after mastectomy. The study, officially registered as ISRCTN61145589, investigated whether omitting chest-wall irradiation could maintain survival outcomes while reducing treatment-related toxicity. Historically, postmastectomy radiotherapy (PMRT) has been standard care for various levels of…
-
Modern Therapies Challenge Radiation’s Role in Early Breast Cancer Survival
Rethinking Postmastectomy Radiation in Early Breast Cancer New evidence from the international phase 3 SUPREMO trial is prompting clinicians to rethink the standard use of chest-wall irradiation after mastectomy for patients with intermediate-risk early breast cancer (eBC). The study explored whether omitting radiotherapy could maintain survival while reducing treatment-related harms, a question that directly affects…
-
Cancer Patients See Longer Lives When Vaccinated Against COVID, New Study Claims
Overview: A bold claim about COVID vaccination and cancer survival A recent media appearance by Professor Luke O’Neill brought attention to a claim that the COVID-19 vaccine could significantly extend survival for cancer patients. Speaking on the Pat Kenny show on Newstalk, the renowned immunologist said that the mRNA vaccine is now credited with boosting…
-
Cancer Patients Significantly Benefit from Covid Vaccination, New Study Suggests
New Findings Link Covid Vaccination to Improved Survival in Cancer Patients A recent discussion by Professor Luke O’Neill on The Pat Kenny Show has brought attention to an assertion that Covid-19 vaccination may increase survival rates among cancer patients. While the specifics of the study are not fully detailed in the broadcast excerpt, the claim…